tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SRPT is currently covered by 23 analysts with an average price target of $21.08. This is a potential upside of $16.7 (34.44%) from yesterday's end of day stock price of $15.68.
Sarepta Therapeutics's activity chart (see below) currently has 627 price targets and 594 ratings on display. The stock rating distribution of SRPT is 41.3% HOLD, 36.96% SELL and 21.74% BUY.
Analysts average stock forecasts to be materialized ratio is 47.47% with an average time for these price targets to be met of 224.24 days.
Highest price target for SRPT is $37, Lowest price target is $12, average price target is $21.08.
Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 09-Jul-2026. First documented stock forecast 20-Mar-2013.
Currently out of the existing stock ratings of SRPT, 19 are a HOLD (41.3%), 17 are a SELL (36.96%), 10 are a BUY (21.74%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jun-2025
$20
$4.32 (27.55%)
$16
18 days ago
(09-Jul-2026)
7/17 (41.18%)
$-0.52 (-2.53%)
71
Sell Since 24-Jul-2025
$13
$-3.85 (-22.85%)
4 months 1 days ago
(26-Mar-2026)
0/2 (0%)
$-8.68 (-40.04%)
Sell Since 22-Jul-2025
4 months 1 days ago
(26-Mar-2026)
14/35 (40%)
$28.03 (127.58%)
364
Buy Since 19-Mar-2026
$37
$20.15 (119.58%)
$50
4 months 8 days ago
(19-Mar-2026)
0/16 (0%)
$20.35 (122.22%)
Buy Since 13-Mar-2026
$31
$14.15 (83.98%)
$19
4 months 14 days ago
(13-Mar-2026)
4/14 (28.57%)
$14.6 (89.02%)
322
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?
